Sinopharm’s BBIBP-CorV Vaccine and ChAdOx1 nCoV-19 Vaccine Are Associated with a Comparable Immune Response against SARS-CoV-2

Sinopharm’s BBIBP-CorV Vaccine and ChAdOx1 nCoV-19 Vaccine Are Associated with a Comparable Immune Response against SARS-CoV-2

Coronavirus disease 2019 (COVID-19) has affected millions of people worldwide. During the early stages of vaccination in Egypt, the ChAdOx1 nCoV-19 and BBIBP-CorV vaccines were the most distributed. The aim of this study was to compare the immune responses and short-term efficacies of these two vacc...

Full description

Bibliographic Details
Main Authors: Ahmed Samir Abdelhafiz, Asmaa Ali, Mahmoud M. Kamel, Eman Hasan Ahmed, Douaa M. Sayed, Rania M. Bakry
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Vaccines
Subjects:
COVID-19
SARS-CoV-2
Egypt
ChAdOx1 nCoV-1
BBIBP-CorV
Online Access:https://www.mdpi.com/2076-393X/10/9/1462

Similar Items

Similar Items